2,045.9 (2,132.6) Net increase in cash and cash equivalents 17.3 (884.6) Cash and cash equivalents - ending balance 2,557.3 1,757.7 1. Cash flows from operating activities The Company had cash inflows

the exercise of 96mn units of MACO-W1 (Total of THB 192mn). 312 250 476 110 195 Beginning cash (30-Dec-16) CFO CFI CFF Ending cash (31-Dec-17) 2016 2017 2016 2017 Profitability Ratios Liquidity Ratios

basis), hence the ratios were calculated from the previous year-end figures. 799 1,581 793 * 1,038 1,029 ** Beginning cash (Restated) (31/3/2017) CFO CFI CFF Ending cash (31/12/2017) The third quarter of

financing activities (8,491.2) (4,596.6) Net increase in cash and cash equivalents 95.0 (691.9) Cash and cash equivalents - ending balance 2,635.4 1,919.7 1. Cash flows from operating activities The Company

machine (dialysis solution) higher than the previous year at 12.07 MB, which was resulted from the success in expanding new- customer base during the ending period of 2016. These were resulted to revenue in

discussed further herein is the fiscal year ending 31 December 2017, 2016, and 2015 and has been prepared on consolidated basis. Consolidated financial information 2017 2016 2015 Total assets n bahtmillio

a specified location. 8.2.3 Procedures for normal operation ranging from the beginning until the ending process of critical business functions, such as, submission of securities trading orders

moving personnel to a specified location. 8.2.3 Procedures for normal operation ranging from the beginning until the ending process of critical business functions, such as, submission of securities trading

statement for year ending December 31, 2018 (1 January – 31 December) for the company and its subsidiaries, detailed as following; Results 2018 Audited Baht 2017 Audited Baht Increase (Decrease) Baht % Total

Decrease in Cash and Cash Equivalents (193.72) (17.68) 176.04 Cash and Cash Equivalent at the Beginning of the Period 1,240.10 736.26 503.83 Cash and Cash Equivalent at the Ending of the Period 1,046.38